NRXS vs WBA
Neuraxis, Inc. (NRXS) versus WBA (WBA) — a side-by-side from cached financials, not a winner call.
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
WBA (WBA) common stock.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
WBA does not have a complete income-statement cache yet.
NRXS currently screens at market cap $83.1M.
Not investment advice. Open the NRXS and WBA stock pages for the full models.
Not investment advice.